| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |